Nano Bugle

A window into applied science supported by INL

Nanomaterials and Influenza Vaccines

Image Obtained from

Image Obtained from

A study published in Advanced Materials and conducted by researchers at the CSIC (Consejo Superior de Investigaciones Científicas) and INIA (Instituto Nacional de Investigación y Tecnología Agraria y Alimentación) could help reduce costs and improve the effectiveness of influenza vaccines, including H1N1, and other infectious agents. The effectiveness of this technique has been tested in animal models and is based on the use of nanomaterials in the group of biocomposites made with components that are commonly used in food and biomedicine.

According to the authors, bionanocomposite silicate natural sepiolite magnesium based and the xanthan polysaccharide would achieve vaccines, administered intramuscularly or intranasally, to immunize with lower doses of antigen.


October 2, 2009 - Posted by | Nanomedicine | ,

No comments yet.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: